Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Stockholders' Equity

v3.21.2
Condensed Consolidated Statements of Changes in Stockholders' Equity - USD ($)
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Total
Balance at the beginning at Dec. 31, 2019 $ 36 $ 3,362,724 $ (8,403,417) $ (5,040,657)
Balance at the beginning (in shares) at Dec. 31, 2019 3,601,521      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation: Options   5,394   5,394
Net loss     (58,098) (58,098)
Balance at the end at Mar. 31, 2020 $ 36 3,368,118 (8,461,515) (5,093,361)
Balance at the end (in shares) at Mar. 31, 2020 3,601,521      
Balance at the beginning at Dec. 31, 2019 $ 36 3,362,724 (8,403,417) (5,040,657)
Balance at the beginning (in shares) at Dec. 31, 2019 3,601,521      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net loss       (1,563,418)
Balance at the end at Jun. 30, 2020 $ 36 3,410,279 (9,966,835) (6,556,520)
Balance at the end (in shares) at Jun. 30, 2020 3,602,633      
Balance at the beginning at Mar. 31, 2020 $ 36 3,368,118 (8,461,515) (5,093,361)
Balance at the beginning (in shares) at Mar. 31, 2020 3,601,521      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation: Options   5,423   5,423
Stock-based compensation: Common stock   3,000   3,000
Stock-based compensation: Common stock (in shares) 1,112      
Forgiveness of accrued expenses by related party   33,738   33,738
Net loss     (1,505,320) (1,505,320)
Balance at the end at Jun. 30, 2020 $ 36 3,410,279 (9,966,835) (6,556,520)
Balance at the end (in shares) at Jun. 30, 2020 3,602,633      
Balance at the beginning at Dec. 31, 2020 $ 118 40,770,504 (16,289,077) 24,481,545
Balance at the beginning (in shares) at Dec. 31, 2020 11,756,109      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Shares issued upon exercise of warrants, net of issuance costs [1] $ 20 9,274,891 0 $ 9,274,911
Shares issued upon exercise of warrants, net of issuance costs (in shares) 2,047,361 [1]     2,047,361
Stock-based compensation: Options $ 0 2,576 0 $ 2,576
Stock-based compensation: Common stock $ 1 513,102 0 513,103
Stock-based compensation: Common stock (in shares) 70,040      
Net loss $ 0 0 (1,796,612) (1,796,612)
Balance at the end at Mar. 31, 2021 $ 139 50,561,073 (18,085,689) 32,475,523
Balance at the end (in shares) at Mar. 31, 2021 13,873,510      
Balance at the beginning at Dec. 31, 2020 $ 118 40,770,504 (16,289,077) $ 24,481,545
Balance at the beginning (in shares) at Dec. 31, 2020 11,756,109      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation: Common stock (in shares)       70,040
Net loss       $ (3,499,617)
Balance at the end at Jun. 30, 2021 $ 143 51,560,228 (19,788,694) 31,771,677
Balance at the end (in shares) at Jun. 30, 2021 14,252,886      
Balance at the beginning at Mar. 31, 2021 $ 139 50,561,073 (18,085,689) 32,475,523
Balance at the beginning (in shares) at Mar. 31, 2021 13,873,510      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Shares issued upon exercise of warrants, net of issuance costs [2] $ 1 428,718 0 $ 428,719
Shares issued upon exercise of warrants, net of issuance costs (in shares) 108,961 [2]     108,961
Common stock issued upon exercise of options $ 0 8,361 0 $ 8,361
Number of shares issued in exercise of stock options 2,815      
Shares issued as partial consideration for intangible asset $ 1 531,999 0 532,000
Shares issued as partial consideration for intangible asset (in shares) 100,000      
Stock-based compensation: Options $ 0 2,509 0 2,509
Stock-based compensation: Common stock $ 2 27,568 0 27,570
Stock-based compensation: Common stock (in shares) 167,600      
Net loss $ 0 0 (1,703,005) (1,703,005)
Balance at the end at Jun. 30, 2021 $ 143 $ 51,560,228 $ (19,788,694) $ 31,771,677
Balance at the end (in shares) at Jun. 30, 2021 14,252,886      
[1] Includes gross proceeds of $9,708,038, less issuance costs of $433,127.
[2] Includes gross proceeds of $460,989, less issuance costs of $32,270.